If you’re attending, visit Ergomed Clinical Research at Booth #71. Our expert team will be available to answer any questions you may have and discuss how Ergomed’s comprehensive rare disease expertise can provide optimal support for your clinical trials, from advanced therapeutic products to pediatric studies.
Don’t miss Juliet speaking at the World Orphan Drug Congress Europe 2024. On October 23 at 17:10, Juliet will present “Leveraging Real World Evidence in Natural History Studies for Rare Disease Clinical Trial Design: RWE and the Value Proposition.” In this session, she will explore how Real World Evidence (RWE) can enhance clinical trial design for rare diseases by incorporating natural history data, ultimately strengthening the value proposition of innovative therapies. Be sure to attend this insightful talk!
To make the most of your visit, we encourage you to schedule a meeting with our rare disease experts to discuss how Ergomed can support your clinical trials. Whether you need assistance with trial design, patient recruitment strategies, or navigating regulatory complexities, our team is here to help you achieve success in the challenging field of rare disease research.
"*" indicates required fields